NasdaqCM - Nasdaq Real Time Price USD
BioXcel Therapeutics, Inc. (BTAI)
1.6800
-0.0300
(-1.75%)
At close: April 22 at 4:00:02 PM EDT
1.6501
-0.03
(-1.78%)
After hours: April 22 at 7:56:36 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-72,027
-72,027
-155,006
-135,341
-82,153
Investing Cash Flow
--
--
-20
-139
-445
Financing Cash Flow
36,660
36,660
26,522
96,237
102,447
End Cash Position
29,854
29,854
65,221
193,725
232,968
Interest Paid Supplemental Data
7,968
7,968
7,551
2,697
40
Capital Expenditure
--
--
-20
-139
-445
Issuance of Capital Stock
39,688
39,688
27,032
--
100,993
Issuance of Debt
--
--
--
98,600
--
Repayment of Debt
-2,500
-2,500
--
--
--
Free Cash Flow
-72,027
-72,027
-155,026
-135,480
-82,598
12/31/2021 - 3/8/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KPTI Karyopharm Therapeutics Inc.
6.03
+11.67%
BLRX BioLineRx Ltd.
2.9000
0.00%
MRSN Mersana Therapeutics, Inc.
0.3760
+15.02%
ADIL Adial Pharmaceuticals, Inc.
0.6778
+1.33%
TCRT Alaunos Therapeutics, Inc.
2.4000
+2.13%
CRIS Curis, Inc.
1.4300
+10.00%
RENB Renovaro Inc.
0.3482
-13.32%
VTYX Ventyx Biosciences, Inc.
1.1800
+4.42%
AFMD Affimed N.V.
0.7390
+5.00%
LGND Ligand Pharmaceuticals Incorporated
106.47
+1.58%